➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Boehringer Ingelheim
Dow
Harvard Business School
Baxter
Express Scripts

Last Updated: August 11, 2020

DrugPatentWatch Database Preview

ATRACURIUM BESYLATE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Atracurium Besylate, and when can generic versions of Atracurium Besylate launch?

Atracurium Besylate is a drug marketed by Aurobindo Pharma Ltd, Baxter Hlthcare, Baxter Hlthcare Corp, Hospira, Hospira Inc, Meitheal, Mylan Labs Ltd, Teva Parenteral, Watson Pharms Teva, West-ward Pharms Int, and Watson Labs Inc. and is included in twenty-two NDAs.

The generic ingredient in ATRACURIUM BESYLATE is atracurium besylate. There are sixteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the atracurium besylate profile page.

US ANDA Litigation and Generic Entry Outlook for Atracurium Besylate

A generic version of ATRACURIUM BESYLATE was approved as atracurium besylate by WEST-WARD PHARMS INT on July 18th, 1997.

  Start Trial

Drug patent expirations by year for ATRACURIUM BESYLATE
Recent Clinical Trials for ATRACURIUM BESYLATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Sir Ganga Ram HospitalN/A
Fayoum University HospitalN/A
Mahidol UniversityPhase 4

See all ATRACURIUM BESYLATE clinical trials

Pharmacology for ATRACURIUM BESYLATE
Medical Subject Heading (MeSH) Categories for ATRACURIUM BESYLATE

US Patents and Regulatory Information for ATRACURIUM BESYLATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd ATRACURIUM BESYLATE atracurium besylate INJECTABLE;INJECTION 206011-001 Apr 8, 2015 AP RX No No   Start Trial   Start Trial   Start Trial
Hospira Inc ATRACURIUM BESYLATE PRESERVATIVE FREE atracurium besylate INJECTABLE;INJECTION 090782-001 Oct 18, 2012 AP RX No No   Start Trial   Start Trial   Start Trial
Meitheal ATRACURIUM BESYLATE atracurium besylate INJECTABLE;INJECTION 091489-001 Feb 17, 2012 AP RX No No   Start Trial   Start Trial   Start Trial
Hospira ATRACURIUM BESYLATE atracurium besylate INJECTABLE;INJECTION 074632-001 Dec 23, 1996 DISCN No No   Start Trial   Start Trial   Start Trial
Aurobindo Pharma Ltd ATRACURIUM BESYLATE PRESERVATIVE FREE atracurium besylate INJECTABLE;INJECTION 206010-001 Apr 8, 2015 AP RX No No   Start Trial   Start Trial   Start Trial
Mylan Labs Ltd ATRACURIUM BESYLATE PRESERVATIVE FREE atracurium besylate INJECTABLE;INJECTION 206001-001 Apr 7, 2017 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
AstraZeneca
Medtronic
Merck
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.